Evidence map›Paper›PMID 35965458›Full record

ArticlePhilosophical transactions. Series A, Mathematical, physical, and engineering sciences2022

Statistical and agent-based modelling of the transmissibility of different SARS-CoV-2 variants in England and impact of different interventions.

J Panovska-Griffiths, B Swallow, R Hinch, J Cohen, K Rosenfeld, R M Stuart, L Ferretti, F Di Lauro, C Wymant, A Izzo and 7 more

Abstract read
In one paragraph

Article in Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2022
    Article
  7. Technical challenges of modelling real-life epidemics and examples of overcoming these.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2022
    Article
  8. The Royal Society RAMP modelling initiative.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2022
    Article
  9. Article
  10. Estimation of age-stratified contact rates during the COVID-19 pandemic using a novel inference algorithm.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2022
    Article
  11. Visualization for epidemiological modelling: challenges, solutions, reflections and recommendations.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

J Panovska-GriffithsThe Big Data Institute and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford.ORCID 0000-0002-7720-1121
B SwallowSchool of Mathematics and Statistics, University of Glasgow, Glasgow, UK.
R HinchThe Big Data Institute and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford.ORCID 0000-0003-3169-698X
J CohenInstitute for Disease Modeling, Bill and Melinda Gates Foundation, Seattle, WA, USA.
K RosenfeldInstitute for Disease Modeling, Bill and Melinda Gates Foundation, Seattle, WA, USA.
R M StuartUniversity of Copenhagen, Copenhagen, Denmark.
L FerrettiThe Big Data Institute and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford.
F Di LauroThe Big Data Institute and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford.
C WymantThe Big Data Institute and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford.
A IzzoInstitute for Disease Modeling, Bill and Melinda Gates Foundation, Seattle, WA, USA.
W WaitesDepartment of Public Health, Environments & Society, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-7759-6805
R VinerUCL Great Ormond St. Institute of Child Health, University College London, London, UK.
C BonellDepartment of Public Health, Environments & Society, London School of Hygiene and Tropical Medicine, London, UK.
C FraserThe Big Data Institute and the Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford.
D KleinInstitute for Disease Modeling, Bill and Melinda Gates Foundation, Seattle, WA, USA.
C C KerrInstitute for Disease Modeling, Bill and Melinda Gates Foundation, Seattle, WA, USA.
COVID-19 Genomics UK (COG-UK) Consortiumhttps://www.cogconsortium.uk.

Funding

Medical Research Council MC_PC_19027
6 · The paper itself

Abstract

The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1.177, Alpha and Delta, and changing restrictions. We used statistical models and the agent-based model Covasim, in June 2021, to estimate B.1.177 to be 20% more transmissible than the wild type, Alpha to be 50-80% more transmissible than B.1.177 and Delta to be 65-90% more transmissible than Alpha. Using these estimates in Covasim (calibrated 1 September 2020 to 20 June 2021), in June 2021, we found that due to the high transmissibility of Delta, resurgence in infections driven by the Delta variant would not be prevented, but would be strongly reduced by delaying the relaxation of restrictions by one month and with continued vaccination. This article is part of the theme issue 'Technical challenges of modelling real-life epidemics and examples of overcoming these'.

Indexed as

COVID-19SARS-CoV-2HumansModels, StatisticalSystems Analysisagent-based modellingCOVID-19multivariate regression modelling

Identifiers

PMID35965458
PMCPMC9376711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.